Cabazitaxel versus docetaxel for treatment of metastatic castrate refractory prostate cancer oleh Nicholas D. James, Ayesha Ali, Ann Pope, Amisha Desai, Daniel Ford, Robert Stevenson, Anjali Zarkar, Sarah Pirrie,  the CANTATA investigators